Standard Biotools (LAB) Leases (2019 - 2025)
Historic Leases for Standard Biotools (LAB) over the last 7 years, with Q3 2025 value amounting to $23.5 million.
- Standard Biotools' Leases fell 2250.53% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year decrease of 2250.53%. This contributed to the annual value of $26.6 million for FY2024, which is 1335.81% down from last year.
- Per Standard Biotools' latest filing, its Leases stood at $23.5 million for Q3 2025, which was down 2250.53% from $24.6 million recorded in Q2 2025.
- Over the past 5 years, Standard Biotools' Leases peaked at $38.7 million during Q2 2021, and registered a low of $23.5 million during Q3 2025.
- In the last 5 years, Standard Biotools' Leases had a median value of $33.0 million in 2024 and averaged $32.4 million.
- Per our database at Business Quant, Standard Biotools' Leases skyrocketed by 432.77% in 2021 and then tumbled by 2250.53% in 2025.
- Quarter analysis of 5 years shows Standard Biotools' Leases stood at $37.1 million in 2021, then decreased by 8.72% to $33.9 million in 2022, then dropped by 9.5% to $30.7 million in 2023, then dropped by 13.36% to $26.6 million in 2024, then fell by 11.72% to $23.5 million in 2025.
- Its last three reported values are $23.5 million in Q3 2025, $24.6 million for Q2 2025, and $27.4 million during Q1 2025.